Laurus Labs Invests INR 1,078 Mn in KRKA Pharma via Rights Issue
Laurus Labs Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 1:39 am
Laurus Labs Invests INR 1,078 Mn in KRKA Pharma via Rights Issue Laurus Labs Limited has invested INR 1,078 Mn to acquire 107.8 Mn equity shares of KRKA Pharma Private Limited at a face value of INR 10 per share via a rights issue, following its prior intimation on 30th Apr'26. KRKA Pharma operates as a joint venture between KRKA d.d., Novo mesto, Slovenia, and Laurus Labs. Post-transaction, Laurus Labs' total holding increases to 262.15 Mn equity shares, maintaining its equity stake unchanged at 49%.
Original exchange filing (PDF)
More announcements from Laurus Labs Ltd
- Please see annexed enclosure. 路 18 Nov 2026
- Please see annexed enclosure. 路 11 Nov 2026
- Please see annexed enclosure. 路 03 Nov 2026
- Please see enclosed annexure. 路 30 Oct 2026
- Please see enclosed annexure 路 29 Oct 2026
- Please see enclosed annexure 路 29 Oct 2026
- Please see enclosed annexure 路 29 Oct 2026
- Appointment of Mr. Kundan Kumar Jha as Joint Company Secretary of the Company w.e.f. November 1, 2026 路 29 Oct 2026
